Medicare does not currently cover GLP-1s for weight loss alone only for diabetes, cardiovascular disease, or sleep apnea but a GLP-1 demonstration program for obesity is expected to begin in mid-2026 for some Medicare enrollees
Antioxidant Properties: Offers antioxidant support to combat oxidative stress and promote overall cellular health
Shimokata K, Yamada Y, Kondo T, Ichihara S, Izawa H, Nagata K, Murohara T, Ohno M, Yokota M
Animal Studies Mouse models provide the bridge between test tubes and humans
[98] (2014) showed that lactaptin effectively inhibited the growth of breast cancer cells (MDA-MB-231) as well as solid tumors induced as xenografts in mice without causing severe side effects